The company is abandoning ovarian and bladder, but still sees a path in endometrial cancer.

The company’s SGR-3515 features among the latest industry projects newly into first-in-human trials.

New clinical trial listings reveal first-in-human studies for Astra’s AZD3470, a new Car-T therapy from Caribou, a B7-H4 challenger and others.

Meanwhile, Bristol Myers Squibb hands back two mystery projects.